Drug prevents, delays Type 1 diabetes in 50% of those at risk, study finds

Half of those at risk for Type 1 diabetes treated with the drug teplizumab remained disease-free five years later, a study published Wednesday by the journal Science Translational Medicine found.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news